 Severe cases are a medical emergency, and are treated with glucocorticoids (steroids), and sometimes ciclosporin.Many anti-inflammatory biological mediators, such as infliximab, etanercept, and anakinra are being tried, but there are no randomized controlled trials demonstrating effectiveness.In mild disease, patients present with eyelid retraction.